Great Point Partners LLC Collegium Pharmaceutical, Inc Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$17.5 - $21.35 $2.12 Million - $2.59 Million
-121,342 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$17.75 - $25.39 $13.1 Million - $18.8 Million
-740,068 Reduced 85.91%
121,342 $2.4 Million
Q1 2021

May 17, 2021
BUY
$19.25 - $26.1 $8.47 Million - $11.5 Million
440,027 Added 104.42%
861,410 $20.4 Million
Q4 2020

Feb 16, 2021
BUY
$17.83 - $22.29 $7.51 Million - $9.39 Million
421,383 New
421,383 $8.44 Million

Others Institutions Holding COLL

# of Institutions
247
Shares Held
37.6M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.1B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email